Trial intelligence / Profile preview

Lacosamide Effects on Alcohol Self Administration

NCT03271528Phase 1Completed

Sponsor
Boston Medical Center
Start
Apr 2018
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in alcohol use disorder (AUD) comparing Lacosamide with Placebo (2 arms). Primary endpoint: Alcohol Consumption in Alcohol Self-Administration Trials at 2 hours. Started Apr 2018; status: completed.

02

Drugs

lacosamide
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT03271528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03271528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call